is of increasing prevalence and believed to result from allergic processes. Helicobacter pylori has been inversely associated with allergic diseases, but there is no known relationship between H pylori, EoE, and esophageal eosinophilia. We investigated the association between esophageal eosinophilia and H pylori infection. METHODS: We performed a crosssectional study of data, collected from a US pathology database, on 165,017 patients in the United States who underwent esophageal and gastric biopsies from 2008 through 2010. Patients with and without H pylori on gastric biopsy were compared, and odds of esophageal eosinophilia were determined. RESULTS: From the data analyzed, 56,301 (34.1%) had normal esophageal biopsy specimens, 5767 (3.5%) had esophageal eosinophilia, and 11,170 (6.8%) had H pylori infection. Esophageal eosinophilia was inversely associated with H pylori (odds ratio [OR], 0.77; 95% confidence interval [CI], 0.69 -0.87). Compared with patients with normal esophageal biopsy specimens, odds of H pylori were reduced among patients with Ն15 eosinophils per highpower field (eos/hpf) (OR, 0.79; 95% CI, 0.70 -0.88), Ն45 eos/hpf (OR, 0.75; 95% CI, 0.61-0.93), Ն75 eos/hpf (OR, 0.72; 95% CI, 0.50 -1.03), and Ն90 eos/hpf (OR, 0.52; 95% CI, 0.31-0.87) (P for trend Ͻ.001). A similar dose-response trend was observed for increasing clinical suspicion for EoE and decreasing prevalence of H pylori. Additionally, severity of histologic effects of H pylori was inversely associated with esophageal eosinophilia. All trends held in multivariate analysis. CONCLUSIONS: In a large cross-sectional analysis, H pylori infection was inversely associated with esophageal eosinophilia. This relationship could have implications for the pathogenesis and epidemiology of EoE.
Caris Institutional Review Board and the University of North Carolina Institutional Review Board approved the study.
Caris Life Sciences is a specialized pathology laboratory serving outpatient endoscopy centers throughout the United States. They review samples from 43 states, Washington DC, and Puerto Rico, with central specimen processing in 1 of 3 laboratories (Irving, TX; Phoenix, AZ; and Boston, MA). Each laboratory follows identical sectioning and staining procedures. An experienced group of subspecialty trained gastrointestinal pathologists originally reviewed the slides for clinical purposes. Biopsy interpretation is performed using a standardized protocol with uniform diagnostic criteria. All biopsy reports are deposited into a central database, which also includes information about patient age, sex, and indication for esophagogastroduodenoscopy (EGD). For the purposes of this study, a de-identified database of preexisting records from unique patients with esophageal biopsy specimens was generated.
Study Population
Cases comprised all patients with esophageal eosinophilia on esophageal biopsy. By definition, cases had histology showing a prominent epithelial infiltration of eosinophils, as described in standardized coding by pathologists (either as "active esophagitis with increased intraepithelial eosinophils" or as an "eosinophilic esophagitis pattern or injury"). 20 Cases were termed "any esophageal eosinophilia."
Controls were all patients with normal esophageal biopsy specimens (unremarkable squamous mucosa). By definition, controls had no evidence of esophageal eosinophilia or other pathologic processes such as noneosinophilic inflammation of any type, epithelial erosion or ulceration, infection with viral or fungal pathogens, or cellular metaplasia, dysplasia, or neoplasia.
The main exposure was the presence of active H pylori infection on gastric biopsy. A diagnosis of Helicobacter gastritis was made when H pylori organisms were detected in a gastric biopsy specimen using an H pylori-specific immunohistochemical stain (anti-H pylori rabbit polyclonal antibody; Cell-Marque, Rocklin, CA) and there was concomitant chronic and/or active inflammation (with or without intestinal metaplasia) in the gastric mucosa, per the updated Sydney classification. 21, 22 Other histologic characteristics of interest included a quantification of the severity of esophageal eosinophilic density in ranges of eosinophils per high-power (400ϫ) field (eos/hpf; area per hpf ϭ 0.237 mm 2 ), the presence of eosinophilic microabscesses (defined as clusters of Ն4 contiguous eosinophils), 23 the presence of reflux esophagitis (defined as a mixed active/chronic inflammatory pattern with squamous papillomatosis and basal hyperplasia), the presence of intestinal metaplasia (Barrett's esophagus), and the presence of infectious esophagitis (defined as histopathologic evidence of either candida, herpes simplex virus, or cytomegalovirus on esophageal biopsy specimens).
Clinical characteristics of interest included upper gastrointestinal symptoms or conditions as derived from the indication for endoscopy (ie, suspected EoE, dysphagia symptoms, reflux symptoms or GERD [defined as a report of heartburn, regurgitation, or reflux], screening or follow-up of a known diagnosis of Barrett's esophagus, abdominal pain or dyspepsia, chest pain, nausea or vomiting, and weight loss or failure to thrive).
Statistical Analysis
Means and SDs were reported for continuous variables. Proportions were reported for categorical data. Bivariate analyses were performed using Student t test for continuous characteristics or Pearson's 2 for categorical characteristics. Unadjusted odds ratios (ORs) were calculated to assess the association between case-control status and the presence of H pylori. To adjust for potential confounders noted on bivariate analysis, multivariate analyses were performed using logistic regression. A backward elimination strategy was used to reduce the model, retaining those covariates for which removal would have caused a change in estimate of Ͼ10% in the estimate of the effect of the association between H pylori and esophageal eosinophilia. The initial model contained age, sex, dysphagia, abdominal pain, and reflux symptoms as defined previously. Age was retained in the final model. Analyses were performed with Stata (version 11.0; StataCorp LP, College Station, TX).
Sensitivity Analyses
We planned for several a priori sensitivity analyses. First, a dose-response analysis was performed for the association between H pylori and increasing levels of esophageal eosinophilia on biopsy (nested categories of Ն15, Ն45, Ն75, and Ն90 eos/ hpf), and a P value for trend was calculated. These categories were chosen empirically based on the available data distributions. In addition, there were some reports in which the level of esophageal eosinophilia was included in the text of the pathology report but there was not an associated standardized pathology code. These cases were included in the "Ն15 eos/hpf" category but were not previously included in the "any esophageal eosinophilia" case definition as described previously.
A second analysis was performed to approximate an increasing clinical likelihood of EoE. We began with patients who were unlikely to have EoE who had pathology consistent with reflux esophagitis. We then applied progressively restrictive limits on the presence of esophageal eosinophilia. First, we defined a group termed "histologic eosinophilic esophagitis," composed of only patients with the standardized pathology interpretation code of "eosinophilic esophagitis pattern of injury" on esophageal biopsy (as outlined previously). We then restricted this group to those who also had an EGD indication of dysphagia or clinical suspicion for EoE and had no histologic evidence of reflux esophagitis or Barrett's esophagus. This definition was then further limited to patients who also had eosinophilic microabscesses in the esophageal epithelium. The last group definition included only patients with Ն90 eos/hpf on esophageal biopsy. We also performed a subanalysis of the association between H pylori and esophageal eosinophilia based on whether the esophageal biopsy was taken from the proximal or distal esophagus.
The final sensitivity analysis examined the association of "histologic eosinophilic esophagitis" with different manifestations of H pylori disease in the stomach, including chronic active gastritis without H pylori present, chronic active gastritis with H pylori present, and intestinal metaplasia present (with or without H pylori). The purpose was to investigate esophageal eosinophilia from the perspective of increasing severity of infection with H pylori. 24, 25 
Results

Patient and Biopsy Characteristics
Between January 1, 2008, and November 26, 2010, a total of 233,662 unique patients had esophageal biopsy specimens reviewed (Table 1 ). The mean age was 55.8 years, and 46.1% were male. The most common indica-tions for endoscopy were GERD (48.6%), abdominal pain (32.9%), and dysphagia (22.6%). There were 26,982 patients (11.6%) who underwent endoscopy for suspected EoE on a clinical basis. We identified 165,017 patients with both esophageal and gastric biopsy specimens. Of these patients, 56,301 (34.1%) had normal esophageal biopsy specimens, 5767 (3.5%) had "any esophageal eosinophilia," and 11,170 (6.8%) had H pylori on gastric biopsy (Table 1) . Although there were many statistical differences given the large sample size between those who had both esophageal and gastric biopsy specimens and those with esophageal biopsy specimens only (Table 1) , for the large majority of variables the absolute difference between groups was 1% or less, differences that were not clinically significant.
Of those with both esophageal and gastric biopsy specimens, patients with esophageal eosinophilia were significantly younger (44 vs 53 years; P Ͻ .001) and more likely to be male (62% vs 35%; P Ͻ .001) compared with patients with normal esophageal biopsy specimens ( Table 2 ). They were also more likely to have an endoscopy indication for suspected EoE or dysphagia and less likely to have an indication for GERD, abdominal pain, or chest pain. Compared with patients without H pylori, patients with H pylori were more likely to have an upper endoscopy indication for abdominal pain and less likely to have an indication for suspected EoE, dysphagia, or Barrett's esophagus (Table 3) . 
Esophageal Eosinophilia and H pylori
The presence of "any esophageal eosinophilia" was inversely associated with H pylori (OR, 0.77; 95% confidence interval [CI], 0.69 -0.87) ( Table 4) . Compared with patients with normal esophageal biopsy specimens, there were reduced odds of H pylori for patients with Ն15 intraepithelial eos/hpf (OR, 0.79; 95% CI, 0.70 -0.88), Ն45 eos/hpf (OR, 0.75; 95% CI, 0.61-0.93), Ն75 eos/hpf (OR, 0.72; 95% CI, 0.50 -1.03), and Ն90 eos/hpf (OR, 0.52; 95% CI, 0.31-0.87) (P for trend Ͻ.001). These associations held after adjusting for potential confounding factors on multivariate analysis (Table 4) .
Increasing clinical suspicion for EoE was also associated with decreasing odds of H pylori. Compared with patients with normal esophageal biopsy specimens, patients with no suspicion of EoE and reflux esophagitis on biopsy had a borderline inverse association with H pylori (OR, 0.95; 95% CI, 0.90 -0.99). Patients with "histologic eosinophilic esophagitis" (as defined previously) had reduced odds of H pylori (OR, 0.72; 95% CI, 0.62-0.83). This inverse association was stronger when limited to those with dysphagia or a clinical suspicion of EoE, no reflux or Barrett's esophagus, and eosinophilic microabscesses (OR, 0.63; 95% CI, 0.45-0.87). Again, all associations held after adjusting for potential confounding factors on multivariate analysis (Table 4) .
There were also differences when evaluating the presence of esophageal eosinophilia in patients with different manifestations of gastritis and H pylori. Compared with patients with normal gastric biopsy specimens, there were reduced odds of "histologic EoE" among patients with chronic active gastritis but no identifiable H pylori (OR, 0.86; 95% CI, 0.64 -1.17), patients with chronic active gastritis and H pylori present (OR, 0.69; 95% CI, 0.59 -0.81), and patients with intestinal metaplasia with or without H pylori (OR, 0.34; 95% CI, 0.23-0.51; P for trend Ͻ.001). These associations also held on multivariate analysis (Table 5) .
Assessment of biopsy location (proximal vs distal) as an effect modifier of the association between H pylori infection and esophageal eosinophilia showed no significant difference based on location of the esophageal biopsy (data and full models not shown).
Discussion
Over the past decade, EoE has become a major cause of dysphagia and morbidity and is commonly encountered in gastroenterology practice. 1,4 -6,8 -13,26 -28 With such a rapidly evolving epidemiology, it is plausible that environmental factors play a role. In some cases, specific food allergens or environmental triggers can be identified. 29 -32 However, the etiology of the dramatic increase in the incidence of EoE is unknown.
The present study used a nationwide pathology database to assess the association between esophageal eosinophilia and H pylori, and the results were striking. We found a strong inverse association between H pylori and esophageal eosinophilia, and as the level of esophageal eosinophilia increased, the odds of H pylori decreased. With increasingly stringent case definitions approximating EoE on a clinical basis, the odds of H pylori also decreased. In addition, the odds of esophageal eosinophilia were lower with progressively chronic manifestations of H pylori disease, as manifest by chronic active gastritis and intestinal metaplasia.
Despite the common nature of both conditions, the literature describing the relationship between H pylori infection and EoE is scant and conflicting. An inverse association of H pylori and esophageal eosinophilia has been suggested in one prior report. 6 In this secondary analysis of a population-based study of the prevalence of Barrett's esophagus, distal esophageal biopsy specimens were re-reviewed for eosinophil counts. However, there were only 48 patients with esophageal eosinophilia and 8 with H pylori. The reported OR in this study was 0.41, similar to our results. In contrast, a study of eosinophilia throughout all segments of the gastrointestinal tract found that patients with H pylori gastritis had somewhat higher esophageal eosinophil counts than patients without H pylori. This study, too, was limited by small numbers, with only 8 patients with eosinophil counts Ն15 eos/hpf. 33 To our knowledge, there have been no prior investigations that also examined esophageal eosinophilia in relation to the manifestation of H pylori in the stomach.
There are several possible explanations for our findings. H pylori has been inversely associated with conditions such as asthma, allergic rhinitis, and atopic dermati- tis. 16 -19 Given that EoE is believed to be an allergic condition, it makes sense that the same association exists. The hygiene hypothesis has been used to attribute the recent increase in all allergic diseases to improved sanitation and reductions in childhood infections, and H pylori is typically contracted during childhood. 15, 16, 34 From a mechanistic perspective, a Th2-mediated allergic response is involved in the pathogenesis of EoE, 14, [35] [36] [37] whereas H pylori may drive a Th1 response 16 with the regulatory T-cell population further modulating the Th1-Th2 balance. It is intriguing to hypothesize, as has been proposed with other allergic conditions, 16, 38 that early infection with H pylori might predispose toward a Th1 response and "protect" from an allergic Th2 response and in turn esophageal eosinophilia. The observations of the lower odds of H pylori with increasing esophageal eosinophilia, and also the low odds of esophageal eosinophilia in subjects with intestinal metaplasia (arguably a manifestation of chronic infection and potentially a committed Th1 inflammatory response to H pylori 24 ), may lend some credence to this hypothesis. We observe that the exact mechanisms of immune modulation of allergy by chronic infections are largely unknown, with the model of Th1 versus Th2 responses most likely representing a simplication. 39 For example, recent studies have shown that H pylori may inhibit the Th17 response and alter the T regulatory cell balance, 39 and H pylori-derived DNA itself may directly inhibit a Th1 response. 40 It remains to be determined whether our findings are attributable to physiologic reflux of H pylori or its DNA, a field effect related to systemic immune alterations, or a different mechanism. In the present study, however, we did not see a clear trend by biopsy level in the esophagus for the inverse association between H pylori and esophageal eosinophilia, c There are some reports in which the level of esophageal eosinophilia was included in the text of the pathology report but there was not an associated standardized pathology code. These cases were included in the "Ն15 eos/hpf" category but could not be included in the "any esophageal eosinophilia" case definition. arguing against direct exposure of H pylori or its DNA as a causal factor for the observed association. Several potential limitations must be considered when interpreting these data. First, because this study was retrospective and cross-sectional in nature, we were unable to draw conclusions about causality or mechanisms, only about associations. Second, we had to restrict our primary outcome to the presence of esophageal eosinophilia, not to EoE itself. This is because current consensus guidelines hold that EoE is a clinicopathologic condition and require exclusion of competing causes of esophageal eosinophilia, including GERD, before the diagnosis of EoE can only be made on a clinical basis. 1 However, we recognized this possible limitation while designing the study and incorporated sensitivity analyses to specifically address this issue. The results of these analyses further support our conclusions. In particular, we observed a stronger inverse association as we assessed progressively more specific EoE case definitions with higher eosinophil counts, supportive histopathologic findings like eosinophilic microabscesses, and exclusion of reflux esophagitis and Barrett's esophagus.
Issues of possible confounding must also be considered. One possibility is that H pylori infection is not causally protective for esophageal eosinophilia but is instead a marker for general microbial or environmental exposures or other allergic conditions. If this were the case, however, it would be unlikely that the odds of esophageal eosinophilia would be lower with a chronic manifestation of H pylori such as intestinal metaplasia. It is also possible that GERD or proton pump inhibitor use could be confounding factors. H pylori is harder to detect in patients on concurrent proton pump inhibitor therapy 41 ; thus, if patients had esophageal eosinophilia due to GERD and were treated with a proton pump inhibitor, it stands to reason that the prevalence of H pylori would be lower. In addition, H pylori can reduce gastric acid secretion, which may also have an impact on esophageal eosinophilia. However, when we controlled for reflux symptoms on multivariable analysis, there was no change in the observed association; in addition, when patients with reflux esophagitis or histologically confirmed Barrett's esophagus were excluded in our more stringent case definition, the OR for H pylori was farther from the null, the opposite of what would be expected if GERD were a confounder. The careful pathologic characterization of a large number of esophageal biopsy specimens using a standardized system of interpretation, in combination with the sensitivity analyses performed for this study, lend validity to our results. This is by far the largest number of subjects with esophageal eosinophilia analyzed in the medical literature.
In conclusion, we found that there was a strong inverse association between H pylori infection and esophageal eosinophilia in biopsy specimens from a large US national pathology database with a patient population reflective of general gastroenterology practice. The odds of H pylori decreased in a dose-response fashion with increasing levels of esophageal eosinophilia and with increasingly restrictive pathologic definitions of EoE. In addition, the odds of esophageal eosinophilia decreased with chronic manifestations of H pylori gastritis and intestinal metaplasia. Although the results of this study cannot speak to causality or biologic mechanisms, this association may have important implications for future research into understanding the pathogenesis and evolving epidemiology of EoE.
